XML 87 R73.htm IDEA: XBRL DOCUMENT v3.20.4
14. Segment Reporting (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Segment Reporting Information [Line Items]      
Number Of Products And Services 9,000    
Net sales $ 2,545,600 $ 2,311,700 $ 2,289,400
Interest expense 21,861 23,416 23,962
Depreciation and amortization 138,100 134,200 138,100
Segment profit 410,957 229,661 (103,341)
Total assets 12,972,618 8,008,859  
Payments to Acquire Property, Plant, and Equipment 98,920 98,532 129,825
Life Science [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,231,800 885,900 861,700
Interest expense 8,000 7,400 7,200
Depreciation and amortization 32,800 29,400 34,100
Segment profit 256,300 72,100 28,700
Total assets 607,300 496,100  
Payments to Acquire Property, Plant, and Equipment 16,800 16,600  
Clinical Diagnostics [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,305,200 1,412,000 1,411,800
Interest expense 13,800 15,900 16,700
Depreciation and amortization 65,100 71,700 72,000
Segment profit 149,100 148,500 (145,700)
Total assets 1,065,600 1,075,800  
Payments to Acquire Property, Plant, and Equipment 43,600 58,900  
All Other Segments [Member]      
Segment Reporting Information [Line Items]      
Net sales 8,600 13,800 15,900
Interest expense 100 100 100
Depreciation and amortization 1,000 900 500
Segment profit (600) (1,500) $ 200
Total assets 9,500 9,200  
Payments to Acquire Property, Plant, and Equipment $ 3,100 $ 600